Condition: Epilepsies, Partial · Sponsor: Ono Pharmaceutical Co., Ltd.
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
This description comes directly from the study's public registry record.
North America Clinical Trial Support Desk · +18665877745(Toll-Free) · clinical_trial@ono-pharma.com
International Clinical Trial Support Desk · +17162141777(Standard) · clinical_trial@ono-pharma.com
Always discuss trial participation with your own doctor first.
| Ehime University Hospital | Ehime, Japan | Recruiting |
| Department of Neurology and Stroke Center, Southern Tohoku Clinic. | Fukushima, Japan | Recruiting |
| Hiroshima University Hospital | Hiroshima, Japan | Recruiting |
| NHO Kure Medical Center and Chugoku Cancer Center | Hiroshima, Japan | Recruiting |
| Asahikawa Medical University Hospital | Hokkaido, Japan | Recruiting |
| Itami City Hospital | Hyōgo, Japan | Recruiting |
| JA-Ibaraki Tsuchiura Kyodo General Hospital | Ibaraki, Japan | Recruiting |
| University of Tsukuba Hospital | Ibaraki, Japan | Recruiting |
| Kagoshima University Hospital | Kagoshima, Japan | Recruiting |
| Tanaka Neurosurgical Clinic | Kagoshima, Japan | Recruiting |
| St. Marianna University School of Medicine Hospital | Kanagawa, Japan | Recruiting |
| Yokohama City University Hospital | Kanagawa, Japan | Recruiting |
+ 17 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06590896